Financial Sense Advisors, Inc. Merck & Co., Inc. Transaction History

Financial Sense Advisors, Inc.

$457 Million
Q3 2025

A detailed history of Financial Sense Advisors, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Financial Sense Advisors, Inc. holds 47,977 shares of MRK stock, worth $4.46 Million. This represents 0.88% of its overall portfolio holdings.

Number of Shares

47,977

Previous 3,500 1270.77%

Holding current value

$4.46 Million

Previous $277,000 1353.43%

% of portfolio

0.88%

Previous 0.08%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$77.6 - $87.37 $3.45 Million - $3.89 Million	44,477 Added 1270.77%	47,977 $4.03 Million
Q2 2025 Aug 05, 2025	BUY	$73.47 - $87.12 $257,145 - $304,920	3,500 New	3,500 $277,000
Q4 2024 Jan 31, 2025	SELL	$96.31 - $114.76 $94,961 - $113,153	-986 Reduced 6.64%	13,859 $1.38 Million
Q3 2024 Oct 31, 2024	BUY	$111.15 - $128.97 $132,824 - $154,119	1,195 Added 8.75%	14,845 $1.69 Million
Q2 2024 Jul 23, 2024	BUY	$123.8 - $132.96 $160,816 - $172,715	1,299 Added 10.52%	13,650 $1.69 Million

Q1 2024 Apr 19, 2024	SELL	$113.24 - $131.95 $57,412 - $66,898	-507 Reduced 3.94%	12,351 $1.63 Million
Q4 2023 Jan 12, 2024	SELL	$100.18 - $109.02 $13,323 - $14,499	-133 Reduced 1.02%	12,858 $1.4 Million
Q3 2023 Nov 06, 2023	SELL	$102.95 - $114.33 $710,663 - $789,219	-6,903 Reduced 34.7%	12,991 $1.34 Million
Q2 2023 Aug 02, 2023	SELL	$108.61 - $118.38 $178,989 - $195,090	-1,648 Reduced 7.65%	19,894 $2.3 Million
Q1 2023 Apr 24, 2023	SELL	$102.94 - $114.86 $145,763 - $162,641	-1,416 Reduced 6.17%	21,542 $2.29 Million
Q4 2022 Feb 06, 2023	BUY	$87.44 - $112.11 $214,752 - $275,342	2,456 Added 11.98%	22,958 $2.55 Million
Q3 2022 Oct 13, 2022	SELL	$84.53 - $94.96 $6,508 - $7,311	-77 Reduced 0.37%	20,502 $1.77 Million
Q2 2022 Jul 18, 2022	BUY	$83.49 - $94.64 $1.72 Million - $1.95 Million	20,579 New	20,579 $1.88 Million
Q1 2022 May 05, 2022	SELL	$73.51 - $82.4 $1.44 Million - $1.61 Million	-19,533 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$72.28 - $90.54 $157,714 - $197,558	2,182 Added 12.58%	19,533 $1.5 Million
Q3 2021 Nov 03, 2021	BUY	$71.68 - $78.83 $238,192 - $261,952	3,323 Added 23.69%	17,351 $1.3 Million
Q2 2021 Jul 29, 2021	BUY	$70.31 - $77.77 $288,763 - $319,401	4,107 Added 41.4%	14,028 $1.09 Million
Q1 2021 Apr 28, 2021	BUY	$68.86 - $81.11 $230,130 - $271,069	3,342 Added 50.8%	9,921 $765,000
Q4 2020 Feb 03, 2021	BUY	$71.77 - $79.65 $10,478 - $11,628	146 Added 2.27%	6,579 $538,000
Q3 2020 Oct 21, 2020	BUY	$73.18 - $82.95 $269,595 - $305,587	3,684 Added 134.01%	6,433 $534,000
Q2 2020 Jul 20, 2020	BUY	$70.42 - $80.13 $193,584 - $220,277	2,749 New	2,749 $213,000

Others Institutions Holding MRK

# of Institutions

3,937

Shares Held

1.9B

Call Options Held

30.1M

Put Options Held

27.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $235B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Sense Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Financial Sense Advisors, Inc. with notifications on news.

Account

Financial Sense Advisors, Inc. Merck & Co., Inc. Transaction History